临床试验/IRCT20200407046981N11

IRCT20200407046981N11尚未招募未知

Randomized, single-dose, crossover comparative bioequivalence study of the Celecoxib 200 mg capsules produced by Daana pharmaceutical Co versus Celebrex® (Pfizer company) in 24 healthy males under fasting conditions

Daana pharmaceutical company0 个研究点目标入组 24 人开始时间: 待定最近更新: 2021年7月12日

试验速览

阶段: 未知
状态: 尚未招募
发起方
入组人数: 24

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

年龄范围: 18 years 至 60 years（—）
性别: Male

入选标准

•The weight limit for each volunteer is between 60 and 100 kg.
•All volunteers must be non-smokers.
•They must be healthy in terms of liver, kidney, respiratory system, mental and other general health characteristics that will be assessed.

排除标准

•Known hypersensitivity or idiosyncratic reaction to Celecoxib or any ingredients.
•Subjects with BP = 90/60 mm/Hg or BP = 140/90 mm/Hg.
•Regular smoker who smokes more than ten cigarettes daily.
•Taking any medicine during two week before dosing.

研究者

发起方

Daana pharmaceutical company

相似试验

bioequivalence study of Metformin 100 mg + Sitagliptin 50 mg tablets in 24 healthy male under fasting conditions

IRCT20180620040164N15Actover co24

Study of absorption and elimination rate of Esomeprazole 10 mg sachet in comparison with standard sachet of Esomeprazole (Nexium®).In this study, the disease is not examined. The subject of the study is the bioequivalence study of the Esomeprazole 10 mg of test and reference in healthy volunteers..

IRCT20200407046981N12???? ???????? ????? ????? ????????24

Study of absorption and elimination rate of Atorvastatin 40 mg tablets in comparison with standard tablets of Atorvastatin (Lipitor®).Bioequivalence study.

IRCT20200407046981N16Daana pharmaceutical company24

bioequivalence study of Gliclazide 30 mg MR tablet in 24 healthy male under fasting conditionsdiabetes mellitus.Type 1 diabetes mellitus

IRCT20180620040164N53ACtover Pharmaceutical Co.24

Study of absorption and elimination rate of Meloxicam 15 mg tablets in comparison with standard tablets of Meloxicam (Mobic®).

IRCT20200407046981N13Daana pharmaceutical company24